Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians. (February 2013)
- Record Type:
- Journal Article
- Title:
- Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians. (February 2013)
- Main Title:
- Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians
- Authors:
- Verbrugge, Frederik H.
Dupont, Matthias
de, Philippe
Rivero‐Ayerza, Maximo
Van Herendael, Hugo
Vercammen, Jan
Jacobs, Linda
Verhaert, David
Vandervoort, Pieter
Tang, W.H. Wilson
Mullens, Wilfried - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ejhfhfs151-sec-0001" sec-type="section"> <title>Aims</title> <p>Cardiac resynchronization therapy (CRT) leads to reverse ventricular remodelling, improved functional capacity, and better clinical outcome in patients with advanced chronic heart failure, reduced ejection fraction, and evidence of ventricular conduction delay, who are under optimal medical therapy. This study investigated whether these benefits can be extrapolated to older patients, typically not included in randomized clinical trials.</p> </sec> <sec id="ejhfhfs151-sec-0002" sec-type="section"> <title>Methods and results</title> <p>Consecutive patients who received a CRT device between October 2008 and June 2011, including optimization afterwards in a dedicated clinic, were stratified into 3 pre‐specified groups, according to age: &lt;70 years (<italic>n</italic> = 76); 70–79 years (<italic>n</italic> = 95); and ≥80 years (<italic>n</italic> = 49). Left ventricular remodelling, functional capacity, heart failure hospitalization, and mortality data were assessed during follow‐up. Reverse left ventricular remodelling and improvement in New York Heart Association functional class were similar in all groups at 6 months after implantation. During mean follow‐up of 20 months, 32 patients died and 66 were admitted for heart failure. Annualized mortality rates were significantly higher in elderly patients (6% vs. 8% vs. 15%<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ejhfhfs151-sec-0001" sec-type="section"> <title>Aims</title> <p>Cardiac resynchronization therapy (CRT) leads to reverse ventricular remodelling, improved functional capacity, and better clinical outcome in patients with advanced chronic heart failure, reduced ejection fraction, and evidence of ventricular conduction delay, who are under optimal medical therapy. This study investigated whether these benefits can be extrapolated to older patients, typically not included in randomized clinical trials.</p> </sec> <sec id="ejhfhfs151-sec-0002" sec-type="section"> <title>Methods and results</title> <p>Consecutive patients who received a CRT device between October 2008 and June 2011, including optimization afterwards in a dedicated clinic, were stratified into 3 pre‐specified groups, according to age: &lt;70 years (<italic>n</italic> = 76); 70–79 years (<italic>n</italic> = 95); and ≥80 years (<italic>n</italic> = 49). Left ventricular remodelling, functional capacity, heart failure hospitalization, and mortality data were assessed during follow‐up. Reverse left ventricular remodelling and improvement in New York Heart Association functional class were similar in all groups at 6 months after implantation. During mean follow‐up of 20 months, 32 patients died and 66 were admitted for heart failure. Annualized mortality rates were significantly higher in elderly patients (6% vs. 8% vs. 15% in all groups, respectively; <italic>P</italic> &lt; 0.001), but time to death or first heart failure admission was similar among age groups (<italic>P</italic> = 0.531). Progressive pump failure was the major cause of death (50%), with co‐morbidity‐related deaths also being frequent (41%).</p> </sec> <sec id="ejhfhfs151-sec-0003" sec-type="section"> <title>Conclusion</title> <p>Reverse left ventricular remodelling and functional capacity improvement after CRT are sustained at advanced age. Moreover, time to all‐cause mortality or heart failure admission was similar, irrespective of age, in a context of maximized optimization including optimal medical therapy.</p> </sec> </abstract> … (more)
- Is Part Of:
- European journal of heart failure. Volume 15:Number 2(2013)
- Journal:
- European journal of heart failure
- Issue:
- Volume 15:Number 2(2013)
- Issue Display:
- Volume 15, Issue 2 (2013)
- Year:
- 2013
- Volume:
- 15
- Issue:
- 2
- Issue Sort Value:
- 2013-0015-0002-0000
- Page Start:
- 203
- Page End:
- 210
- Publication Date:
- 2013-02
- Subjects:
- Heart failure -- Periodicals
Heart Failure -- Periodicals
Insuffisance cardiaque -- Périodiques
Heart failure
Periodicals
616.129005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1879-0844 ↗
http://rave.ohiolink.edu/ejournals/issn/13889842/ ↗
http://www.sciencedirect.com/science/journal/13889842 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1093/eurjhf/hfs151 ↗
- Languages:
- English
- ISSNs:
- 1388-9842
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.729860
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3383.xml